Replies to post #164937 on Biotech Values

[DewDiligence]

ZTS +2% on solid, though not spectacular, quarter:

http://finance.yahoo.com/news/zoetis-reports-second-quarter-2013-110000297.html

Foreign exchange shaved 2% from 2Q13 sales, but the tax rate (one of my reasons for buying this name—see #msg-85781758) held at 29%.